Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-002613

Chief Financial Officer sold 20,000 shares at an average $60.11 ($1,202,201)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-06 Sale : show line 1 in the form −7,593 $59.60 $452,543 403,592 D
2020-01-06 Sale : show line 2 in the form −11,907 $60.40 $719,183 391,685 D
2020-01-06 Sale : show line 3 in the form −500 $60.95 $30,475 391,185 D
Open-market sales · 20,000 sh · avg $60.11 · $1,202,201
Loading xslF345X03/doc4.xml…